Nuvalent Inc - Class A — Balance Sheet (NASDAQ:NUVL) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 293.82 M482.46 M732.38 M1.14 B1.41 B Total liabilities 8.79 M19.48 M31.82 M71.96 M164.37 M Total equity 285.04 M462.98 M700.56 M1.07 B1.25 B Total liabilities & shareholders' equities 293.82 M482.46 M732.38 M1.14 B1.41 B Total debt ————— Net debt —————

News

Nuvation Bio earnings in focus: Ibtrozi momentum faces test

Does Nuvalent (NUVL) Have the Potential to Rally 37.26% as Wall Street Analysts Expect?

Nuvalent reports Q4 loss, awaits FDA decision on lung cancer drug

Drugmakers turn to AI to speed trials, regulatory submissions

Nuvalent Inc stock hits 52-week high at 112.89 USD

FDA accepts Nuvalent’s NDA for ROS1-positive NSCLC treatment

Nuvalent (NUVL) chief legal officer Miller sells $676k in stock

Nuvalent CSO Pelish sells shares worth $501,752

Nuvalent (NUVL) chief development officer sells $721k in stock

What's Going On With Royalty Pharma Stock Wednesday? - Royalty Pharma (NASDAQ:RPRX)

3 Biotech Stocks With Major 2026 Catalysts

UBS reiterates Buy rating on Nuvalent stock, citing Royalty Pharma deal